Trial intelligence / Profile preview

Ductal Lavage vs Corticosteroids for Idiopathic Granulomatous Mastitis

NCT03724903Completed

Sponsor
Sun Yat-sen Memorial Hospital
Start
Apr 2019
Primary completion
Apr 2023
Countries
1
01

Overview

Randomised, open-label trial of triamcinolone acetonide in idiopathic granulomatous mastitis (IGM), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Complete Clinical Response at 1 year. Started Apr 2019; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

idiopathic granulomatous mastitis (IGM)

Beyond the preview

Go deeper on NCT03724903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03724903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call